INS and type 1 diabetes mellitus: Additionally, despite modern improvements in insulins, which have increased the healthy lifespan of people living with T1D, there are growing financial barriers to affordable access in many countries [5,6] and an overall high risk of cardiovascular disease development, which is a major cause of death among older people living with T1D [7].